STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Certara (NASDAQ: CERT) announced it will release its Q4 and full-year 2024 financial results after market close on February 26th, 2025. Management will host a conference call at 5:00 PM ET to discuss the results, with advance registration required for investors.

Additionally, the company's management team will participate in two upcoming investor conferences in March: the Leerink Partners Global Healthcare Conference on March 11th at 1:00 PM ET and the Barclays 27th Annual Global Healthcare Conference on March 12th at 11:30 AM ET. Live and archived webcasts of these events will be available on Certara's investor relations website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

RADNOR, Pa., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the fourth quarter and full year of 2024 after the market close on Wednesday, February 26th, 2025. Company management will host a conference call to discuss financial results at 5:00PM ET.

Investors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance.

Certara also announced that company management will participate in the following investor conferences:

  • Leerink Partners Global Healthcare Conference
    Date and Time: Tuesday, March 11th at 1:00PM ET
  • Barclays 27th Annual Global Healthcare Conference
    Date and Time: Wednesday, March 12th at 11:30AM ET

Live and archived webcasts of these events will be available on the “Investors” section of the Certara website at https://ir.certara.com/.

About Certara
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. Learn more at certara.com.

Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com

Media Contact:
Alyssa Horowitz
certara@pancomm.com


FAQ

When will Certara (CERT) release its Q4 and full-year 2024 earnings?

Certara will release its Q4 and full-year 2024 financial results after market close on Wednesday, February 26th, 2025.

What time is Certara's Q4 2024 earnings conference call?

Certara's Q4 2024 earnings conference call is scheduled for 5:00 PM ET on February 26th, 2025.

Which investor conferences will Certara attend in March 2025?

Certara will participate in the Leerink Partners Global Healthcare Conference on March 11th and the Barclays 27th Annual Global Healthcare Conference on March 12th, 2025.

Where can investors access Certara's conference webcasts?

Live and archived webcasts of Certara's investor conferences will be available on the 'Investors' section of their website at https://ir.certara.com/.
Certara, Inc.

NASDAQ:CERT

CERT Rankings

CERT Latest News

CERT Latest SEC Filings

CERT Stock Data

1.38B
118.73M
2.51%
104.2%
8.37%
Health Information Services
Services-prepackaged Software
Link
United States
RADNOR